Marrone Bio Innovations, Inc. (MBII) News

Marrone Bio Innovations, Inc. (MBII): $1.13

-0.03 (-2.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MBII to Watchlist
Sign Up

Industry: Chemicals


Ranked

of 90

in industry

Filter MBII News Items

MBII News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MBII News Highlights

  • MBII's 30 day story count now stands at 6.
  • Over the past 8 days, the trend for MBII's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about MBII are BIO, AP and CTVA.

Latest MBII News From Around the Web

Below are the latest news stories about Marrone Bio Innovations Inc that investors may wish to consider to help them evaluate MBII as an investment opportunity.

Koppers (KOP) Q4 Earnings Beat Estimates

Koppers (KOP) delivered earnings and revenue surprises of 14.93% and 1.56%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Marrone Bio Innovations CFO Sue Cheung to step down

Marrone Bio Innovations (NASDAQ:MBII) said CFO Sue Cheung will resign for personal reasons, effective Mar. 9. LaDon Johnson, a director with CFO Systems, has been appointed interim CFO on a consulting basis while MBII begins a national search for a permanent CFO....

Seeking Alpha | February 22, 2022

Marrone Bio Announces CFO Transition

RALEIGH, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, announced today a transition of its Chief Financial Officer role. Current CFO Sue Cheung has chosen to resign for personal reasons, effective March 9, 2022. LaDon Johnson, a director with CFO Systems, has been appointed interim CFO on a consulting basis while the company begins a national search for a permanent CFO. “We ap

Yahoo | February 22, 2022

Marrone Bio Innovations Inc. (NASDAQ: MBII) Stock Seems Like A Good Option

Marrone Bio Innovations Inc. (NASDAQ:MBII) shares, rose in value on Friday, 02/18/22, with the stock price down by -2.92% to the previous days close as strong demand from buyers drove the stock to $0.65. Actively observing the price movement in the last trading, the stock closed the session at $0.67, falling within a range of Marrone Bio Innovations Inc. (NASDAQ: MBII) Stock Seems Like A Good Option Read More »

Stocks Register | February 19, 2022

Marrone Bio Innovations (NASDAQ:MBII) investors are sitting on a loss of 74% if they invested a year ago

It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...

Yahoo | February 18, 2022

Marrone Bio and Corteva Agriscience Announce New Distribution Contract

The companies build on existing seed treatment partnership to offer novel foliar bionutrientGENEVA and RALEIGH, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Growers in Europe will have access to a novel, sustainable option for enhancing plant health and crop quality through a new agreement between Pro Farm Technologies, a subsidiary of Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII) and Corteva Agriscience (NYSE: CTVA). Under the agreement, Corteva will be the exclusive European distributor for Ki

Yahoo | February 15, 2022

Cannabis Stock Gainers And Losers From January 20, 2022

GAINERS: Icanic Brands (OTC: ICNAF ) shares closed up 9.51% at $0.18 Neptune Wellness Solns (NASDAQ: NEPT ) shares closed up 6.20% at $0.44 Cann Gr (OTC: CNGGF ) shares closed up 3.86% at $0.21 LOSERS: Rhinomed (OTC: RHNMF ) shares closed down -14.09% at $0.19 Cannabix Technologies (OTC: BLOZF ) shares closed down -13.85% at $0.56 Item 9 Labs (OTC: INLB ) shares closed down -13.21% at $0.92 Marrone Bio Innovations (NASDAQ: MBII ) shares closed down -8.23% at $0.64 Greenlane Hldgs (NASDAQ: GNLN ) shares closed down -7.96% at $0.76 Full story available on Benzinga.com

Benzinga | January 20, 2022

Marrone Bio Innovations Issues Shareholder Letter

Announces Preliminary Fourth Quarter and Fiscal Year 2021 Financial ResultsRALEIGH, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released an update letter to shareholders from Chief Executive Officer Kevin Helash announcing preliminary financial results for the fourth quarter and fiscal year ended December 31,

Yahoo | January 18, 2022

2 “Strong Buy” Penny Stocks That Could See Outsized Gains

For investors seeking the strongest possible returns, there has always been a clear path. It involves risk, but the rewards are real. We’re talking, of course, about the outsized gains available in penny stocks, the low-priced equities that can slide under the radar. Historically, these are shares that sold for less than an old English shilling – just pennies. Later, they were defined as stocks selling for less than a one dollar per share; today, they’re the shares priced at less than $5. No mat

Yahoo | January 13, 2022

Marrone (MBII) Expands the Existing Inventory Line of Credit

Marrone's (MBII) increase in the line of credit for inventory provides it with greater flexibility to support its commercial expansion in the future.

Yahoo | January 10, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.454 seconds.